D. Ryan Daws insider trades

Open-market stock purchases and sales by D. Ryan Daws, Chief Financial Officer at enGene Holdings Inc, from SEC Form 4 filings since Feb 19, 2014.

Recent trades

DateStockTradeValue
Jan 30, 2026ENGN enGene Holdings IncBought (not open market)—

Companies traded

  • ENGN enGene Holdings Inc: other filings, last Jan 30, 2026
  • CNCE Concert Pharmaceuticals, Inc: other filings, last Jan 4, 2017

Get free alerts when D. Ryan Daws files a new trade →